{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1234.26","meta":{"versionId":"6","lastUpdated":"2021-11-23T01:01:49.000-05:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"BEST System Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2021-11-23"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.26","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1234.26"}],"version":"20211123","name":"KawasakiDiseaseICD10CMCodesForAEReporting","title":"Kawasaki Disease, ICD10CM codes for AE reporting","status":"active","experimental":false,"date":"2021-11-23T01:01:49-05:00","publisher":"BEST System Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: Kawasaki Disease definition of ICD10CM diagnosis codes, for potential identification of potential biologics-related adverse events.),(Data Element Scope: This value set may use a model element in the QDM category of Condition/Diagnosis.),(Inclusion Criteria: Kawasaki Disease ICD10CM diagnosis codes.),(Exclusion Criteria: Sequelae and chronic codes may be excluded.)","compose":{"include":[{"system":"http://hl7.org/fhir/sid/icd-10-cm","concept":[{"code":"M30.3","display":"Mucocutaneous lymph node syndrome [Kawasaki]"}]}]},"expansion":{"identifier":"urn:uuid:d184197c-a616-4813-9241-9ce6bcf92443","timestamp":"2023-12-11T00:22:45-05:00","total":1,"contains":[{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2024","code":"M30.3","display":"Mucocutaneous lymph node syndrome [Kawasaki]"}]}}